Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)
Status:
Recruiting
Trial end date:
2022-12-04
Target enrollment:
Participant gender:
Summary
The study to compare to the efficacy and safety of Crinone versus combination medication in
infertile women receive frozen-thawed embryo transfer (FET) in artificial cycles (AC).
Phase:
Phase 4
Details
Lead Sponsor:
Merck KGaA, Darmstadt, Germany
Collaborators:
Merck Serono Co., Ltd. Merck Serono Co., Ltd., Beijing, China